The landscape of healthcare has undergone a significant transformation with the advent of recombinant DNA technology. Among its many achievements, the production of Recombinant Human Proteins stands out as a groundbreaking innovation. These proteins, synthesized through genetic engineering, have opened new horizons[...]
Read MorePhages are viruses that infect bacteria specifically and create more phage proteins resulting in more phage particles. These phages carry immense importance in the field of bioengineering for applications that begin with tissue engineering, and scaffolds to immune signal delivery. There have[…]
Read MoreThe definitive monoclonal antibody (mAb) production procedure involves fusing myeloma cells with desired antibody-producing splenocytes to produce mAb-producing cells (hybridomas) (e.g. B cells). Animals, mainly mice, are used to obtain these B cells; following cell fusion, thousands of clones are screened and[…]
Read MoreTreatment of diseases arose with the concept of antibodies back in the 1890s, by Emil Adolf von Behring. In the further 1960s, there were structural characteristics describers, forward marking discovery of Production Methods Of Monoclonal Antibodies (mAbs). The first mAb, muromonab-CD3, was[…]
Read MoreWhat Are Monoclonal Antibodies (MABs)? Monoclonal antibodies are proteins produced in the laboratory that can bind to body cells, even cancer cells. There are different types of monoclonal antibodies, or MABs, designed to carry out specific functions. At the same time, a[…]
Read MoreMonoclonal Antibody Production is an important part of the research, diagnostics, product, and development that provides several benefits to patients suffering from diverse diseases. They provide a wide range of therapeutic uses for targeted therapy. Monoclonal antibodies or mAbs are capable of[…]
Read MoreAntibodies are giant Y-shaped proteins known as immunoglobulins produced by B cells as a part of the flexible human response when encountering a foreign molecule. Many researchers employ epitopes to identify and detect the target protein of interest in various applications because[…]
Read MoreThe very first monoclonal antibody approved by the U.S. FDA (Food and Drug Administration) in 1997 ushered a new era in therapeutic applications for patients. A clinical breakthrough was acknowledged in the 1990s when there was the successful development of a humanized[…]
Read MoreIntroduction Monoclonal Antibody Drugs are a type of biological therapy that has revolutionized the treatment of several diseases, including cancer, autoimmune diseases, and infectious diseases. Monoclonal antibodies are laboratory-produced molecules that mimic the immune system’s ability to recognize and fight off foreign[…]
Read MoreWhat level of antibody affinity do you require? What will your project’s final application be? Do you have any limits in terms of time or money? If you’re deciding between Hybridoma Technology Steps and phage display for a monoclonal antibodies production project[…]
Read More